Advancing Type 2 Diabetes Management: The Importance Of Interdisciplinary Expertise In Clinical Research

By Peyton Sandroni, Ph.D., Fellow, Clinical Research Methodology, MarieElena Cordisco, MA, NP-C, APRN, Therapeutic Strategy Lead, Cardiovascular & Metabolic, and Michael Murphy, MD Ph.D., Chief Medical and Scientific Officer

Type 2 diabetes (T2D) is a complex, chronic condition requiring tailored medical and lifestyle approaches. Recent breakthroughs across therapeutic areas have transformed the clinical research landscape. To effectively position novel and existing treatments in this dynamic environment, a deep understanding of the interplay between therapeutic areas and regulatory frameworks is essential. This paper explores the convergence of T2D and obesity, emphasizing the need for a CRO with broad expertise beyond cardiometabolic research to drive advancements in T2D management.